• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association between thyroid function and osteopenia or osteoporosis: a cross-sectional study in China.甲状腺功能与骨质减少或骨质疏松之间的关联:一项中国的横断面研究。
Sci Rep. 2025 May 7;15(1):15880. doi: 10.1038/s41598-025-00448-x.
2
High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.甲状腺功能正常的绝经后女性中,游离甲状腺素水平略高于正常范围与低骨小梁评分相关。
Osteoporos Int. 2016 Feb;27(2):457-62. doi: 10.1007/s00198-015-3270-3. Epub 2015 Aug 8.
3
Low Thyroid Stimulating Hormone Levels Are Associated with Low Bone Mineral Density in Femoral Neck in Elderly Women.老年女性中,促甲状腺激素水平低与股骨颈骨密度低有关。
Arch Med Res. 2016 May;47(4):310-4. doi: 10.1016/j.arcmed.2016.07.009.
4
Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population.中年韩国人群的亚临床甲状腺功能障碍、骨密度和骨质疏松症。
Osteoporos Int. 2020 Mar;31(3):547-555. doi: 10.1007/s00198-019-05205-1. Epub 2019 Nov 13.
5
Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.促甲状腺激素与甲状腺激素对绝经前女性骨密度和骨转换的调节作用
Endocr Regul. 2010 Apr;44(2):57-63. doi: 10.4149/endo_2010_02_57.
6
Subclinical thyroid dysfunction and circulating thyroid hormones are not associated with bone turnover markers or incident hip fracture in older men.亚临床甲状腺功能障碍和循环甲状腺激素与老年男性的骨转换标志物或髋部骨折无关。
Clin Endocrinol (Oxf). 2018 Jul;89(1):93-99. doi: 10.1111/cen.13615. Epub 2018 May 15.
7
Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study.促甲状腺激素水平亢进与低骨密度相关:HUNT 2研究
Eur J Endocrinol. 2009 Nov;161(5):779-86. doi: 10.1530/EJE-09-0139. Epub 2009 Aug 11.
8
Evaluation of Bone Mineral Density Using DXA and cQCT in Postmenopausal Patients Under Thyrotropin Suppressive Therapy.应用 DXA 和 cQCT 评估甲状腺激素抑制治疗后绝经后患者的骨密度。
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4232-4240. doi: 10.1210/jc.2017-02704.
9
The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women.绝经后美国女性血清促甲状腺激素处于参考范围内与骨骼状态的关联。
Bone. 2007 Apr;40(4):1128-34. doi: 10.1016/j.bone.2006.12.001. Epub 2007 Jan 22.
10
The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.促甲状腺激素水平在维持绝经后女性骨密度方面似乎较为有利。
Endocr Regul. 2010 Jan;44(1):9-15. doi: 10.4149/endo_2010_01_9.

本文引用的文献

1
Changes in Dietary Nutrient Intake and Estimated Glomerular Filtration Rate over a 5-Year Period in Renal Transplant Recipients.在肾移植受者中,饮食营养素摄入和肾小球滤过率的 5 年变化。
Nutrients. 2023 Dec 31;16(1):148. doi: 10.3390/nu16010148.
2
Distinct Metabolites in Osteopenia and Osteoporosis: A Systematic Review and Meta-Analysis.骨质疏松症和骨质疏松症中的不同代谢物:系统评价和荟萃分析。
Nutrients. 2023 Nov 23;15(23):4895. doi: 10.3390/nu15234895.
3
Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association.甲状腺疾病患者的骨骼健康评估与管理:韩国甲状腺协会立场声明。
Endocrinol Metab (Seoul). 2023 Apr;38(2):175-189. doi: 10.3803/EnM.2023.1701. Epub 2023 Apr 27.
4
Study of the relationship between FT3, FT4, and TSH with bone resorption indices in men with hypothyroidism.研究甲状腺功能减退症男性患者中 FT3、FT4 和 TSH 与骨吸收指标之间的关系。
J Popul Ther Clin Pharmacol. 2022 Jun 16;29(2):e33-e39. doi: 10.47750/jptcp.2022.929. eCollection 2022.
5
UK clinical guideline for the prevention and treatment of osteoporosis.英国临床骨质疏松症预防和治疗指南。
Arch Osteoporos. 2022 Apr 5;17(1):58. doi: 10.1007/s11657-022-01061-5.
6
The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis.全球骨质疏松症的患病率:一项全面的系统评价和荟萃分析。
J Orthop Surg Res. 2021 Oct 17;16(1):609. doi: 10.1186/s13018-021-02772-0.
7
Thyroid Function and Risk of Anemia: A Multivariable-Adjusted and Mendelian Randomization Analysis in the UK Biobank.甲状腺功能与贫血风险:英国生物库中的多变量调整和孟德尔随机化分析。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e643-e652. doi: 10.1210/clinem/dgab674.
8
Osteoporosis in Older Adults.老年人骨质疏松症。
Med Clin North Am. 2020 Sep;104(5):873-884. doi: 10.1016/j.mcna.2020.06.004. Epub 2020 Jul 15.
9
The epidemiology of osteoporosis.骨质疏松症的流行病学。
Br Med Bull. 2020 May 15;133(1):105-117. doi: 10.1093/bmb/ldaa005.
10
Thyroid Hormone Diseases and Osteoporosis.甲状腺激素疾病与骨质疏松症
J Clin Med. 2020 Apr 6;9(4):1034. doi: 10.3390/jcm9041034.

甲状腺功能与骨质减少或骨质疏松之间的关联:一项中国的横断面研究。

Association between thyroid function and osteopenia or osteoporosis: a cross-sectional study in China.

作者信息

Zhang Ling, Ma Chao, Yin Xin, Zhang Fenglian, Fang Xiuyan, Zhang Chen, Shang Lei, Ma Li

机构信息

Department of General Medicine, Heze Hospital Affiliated to Shandong First Medical University, Shandong, 274000, China.

Department of General Medicine, Shandong Provincial Hospital Heze Branch, Shandong, 274000, China.

出版信息

Sci Rep. 2025 May 7;15(1):15880. doi: 10.1038/s41598-025-00448-x.

DOI:10.1038/s41598-025-00448-x
PMID:40335568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12059006/
Abstract

Thyroid dysfunction is associated with bone health, but the relationship with osteopenia remains unclear. This study aimed to investigate the association between thyroid function and osteopenia/osteoporosis across different age groups. The study included 4508 men and 1438 women who underwent health check-ups between January 2021 and December 2023. Bone mineral density (BMD) was measured using dual energy X-ray absorptiometry. Logistic regression analysis was employed to evaluate the association between thyroid function and the risk of osteopenia/osteoporosis. The results showed that in postmenopausal women, both hyperthyroidism and age increased the risk of osteopenia and osteoporosis, while body mass index (BMI) was negatively correlated with both conditions. In men over 50, hyperthyroidism and age were also linked to a higher risk of osteoporosis. Among postmenopausal women, higher thyroid-stimulating hormone (TSH) levels were negatively associated with osteopenia risk. In men aged 50 and above, free thyroxine (fT4) levels were inversely related to osteopenia and osteoporosis risk. In men under 50, fT4 levels were negatively linked to the risk of low bone mass. These findings suggest that TSH and fT4 levels may influence bone health, with these effects varying by age and sex. Further studies are needed to confirm these findings and explore potential mechanisms.

摘要

甲状腺功能障碍与骨骼健康相关,但与骨质减少的关系仍不明确。本研究旨在调查不同年龄组甲状腺功能与骨质减少/骨质疏松之间的关联。该研究纳入了2021年1月至2023年12月期间接受健康检查的4508名男性和1438名女性。使用双能X线吸收法测量骨密度。采用逻辑回归分析评估甲状腺功能与骨质减少/骨质疏松风险之间的关联。结果显示,在绝经后女性中,甲状腺功能亢进和年龄均增加了骨质减少和骨质疏松的风险,而体重指数(BMI)与这两种情况均呈负相关。在50岁以上的男性中,甲状腺功能亢进和年龄也与较高的骨质疏松风险相关。在绝经后女性中,较高的促甲状腺激素(TSH)水平与骨质减少风险呈负相关。在50岁及以上的男性中,游离甲状腺素(fT4)水平与骨质减少和骨质疏松风险呈负相关。在50岁以下的男性中,fT4水平与低骨量风险呈负相关。这些发现表明,TSH和fT4水平可能影响骨骼健康,且这些影响因年龄和性别而异。需要进一步研究来证实这些发现并探索潜在机制。